Daily non-political popular news in brief.

RNA splicing factor implicated in ovarian tumor cell growth

An RNA-binding protein that is overproduced in ovarian cancer may present a new target for diagnosis or treatment of ovarian and other cancers, according to researchers at the University of Illinois at Chicago.

Read more »

Keywords: rna, splicing, factor, implicated, ovarian, tumor, cell, growth

« Previous | Next »

Similar news on "RNA splicing factor implicated in ovarian tumor cell growth":

1. CSHL researchers show RNA splicing factor may be new target for cancer therapy
   02-18-2007 · EurekAlert!
   New results in the field of RNA research establish that the RNA splicing factor SF2/ASF can act as a cancer-causing protein by changing the alternative splicing of other genes critical for growth-control of cells.
   Similar news · Read more »
   
2. 'Clumping' protein linked to return of ovarian cancer
   12-15-2006 · EurekAlert!
   Johns Hopkins scientists have discovered that women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth and slows down cell death, both hallmarks of malignancy.
   Similar news · Read more »
   
3. FOXO factor promotes survival of oxygen-deprived cancer cells
   12-27-2007 · EurekAlert!
   Scientists report that an evolutionarily conserved transcription factor may have both positive and negative effects on the growth of tumors, depending on whether or not the tumor cells have enough oxygen. The research, published by Cell Press in the Dec. 28 issue of Molecular Cell, provides critical new information about how normal cells and cancer cells survive under stress.
   Similar news · Read more »
   
4. Scientists take next step in understanding potential target for Ovarian cancer treatment
   07-16-2007 · EurekAlert!
   A traffic cop protein in the cell may have an even more important role: transporting a messenger protein that tells components in the nucleus to stop cell growth. Scientists are studying the normal function of a protein called 'km23', the traffic cop protein, because the team previously found altered forms of the protein in 42 percent of tumor tissue samples taken from women with Ovarian cancer. The discovery of this additional role may lead to diagnostic tools and earlier treatments for Ovarian cancer.
   Similar news · Read more »
   
5. T-beta-RIII joins the fight against breast cancer
   12-07-2006 · EurekAlert!
   Although the soluble factor TGF-beta suppresses tumor cell growth in early breast cancer, high TGF-beta levels later in disease are associated with a poor outcome. A new study using human breast cancer samples and mice, indicates that changes in expression of one TGF-beta receptor component, T-beta-RIII, might explain the distinct effects of TGF-beta at the different stages of breast cancer and that analysis of T-beta-RIII levels might help clinicians decide how aggressively to treat patients.
   Similar news · Read more »
   
6. Other highlights in the February 7 JNCI
   02-06-2007 · EurekAlert!
   Also in the February 7 JNCI, an article on second cancers among hairy cell leukemia survivors, a test to identify types of colorectal cancer, a report on problems with tumor markers, and a examination of a growth factor that may interfere with blood cell production.
   Similar news · Read more »
   
7. Novel medication improves ovarian cancer treatment
   10-31-2007 · EurekAlert!
   A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anticancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
   Similar news · Read more »
   
8. 'Quiet revolution' may herald new RNA therapeutics
   01-21-2007 · EurekAlert!
   Scientists at the University of Oxford have identified a surprising way of switching off a gene involved in cell division. The mechanism involves a form of RNA, a chemical found in cell nuclei, whose role was previously unknown, and could have implications for preventing the growth of tumour cells.
   Similar news · Read more »
   
9. Human C-reactive protein regulates myeloma tumor cell growth and survival
   09-10-2007 · EurekAlert!
   Scientists report that a protein best known as a common marker of inflammation plays a key role in the progression of human cancer. The research, published by Cell Press in the September issue of the journal Cancer Cell, implicates C-reactive protein (CRP) as a potential target for cancer treatment.
   Similar news · Read more »
   
10. Cold Spring Harbor Protocols highlights a method that captures cell growth and activity
    11-01-2007 · EurekAlert!
    This month's issue of Cold Spring Harbor Protocols features a cutting-edge method that provides a snapshot of growth and activity patterns in mixed populations of cells. It also includes a related classic technique for the quantification of DNA and RNA in solutions.
    Similar news · Read more »